Pharma Data Mining Restriction Options Available
The PDRP "enables physicians to ‘opt out’ of such disclosure quickly and easily, while still allowing their data to be available for academic and governmental research," the AMA statement said.
“We believe the PDRP balances individual physician concerns regarding prescription data with First Amendment freedoms and the fundamental public interest in robust medical research."
Mello and Messing said the Supreme Court decision "may offer an unexpected dividend to opponents of data mining: The surrounding publicity might alert physicians to their right to opt out of sharing their prescribing information through the PDRP."
Cheryl Clark is senior quality editor and California correspondent for HealthLeaders Media. She is a member of the Association of Health Care Journalists.
- CEO Exchange: Preparing for Population Health
- Advocate, NorthShore Deal Would Create 16-Hospital System
- EHR Systems 'Immature, Costly,' AMA Says
- Better HCAHPS Scores Protect Revenue
- Narrow Networks Cut Costs, Not Quality, Economists Say
- 3 Strategies for Retaining Millennial Employees
- 'Early Offer' Malpractice Programs May Spur Reform
- Power of price: In South FL and the nation, healthcare costs often are shrouded in secrecy
- Two NY hospitals to offer free hip and knee replacement surgeries for qualifying patients in December
- Hospital mergers may lead to higher prices